Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy

Journal of Hypertension

Volumn 21, Issue 5, 2003, Pages 993-1001

  Rossi, Marcos A ^a   Ramos, Simone G ^a   Prado, Cibele M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiac hypertrophy; Hypertension; Hypertrophy; Mitochondrial remodelling; N nitro L arginine methyl ester; Nitric oxide; Remodelling; Ultrastructure

Indexed keywords

CAPTOPRIL; COLLAGEN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DECOMPRESSION; DRUG EFFECT; ENZYME INHIBITION; ENZYME SYNTHESIS; HEART; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RAT; SYSTOLIC BLOOD PRESSURE; TIME;

EID: 0037637554     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200305000-00025     Document Type: Article

References (32)

1. Baylis CH, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90:278-281.
2. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992; 20:298-303.
3. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimohawa H, Sueishi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodelling in rats. Hypertension 1995; 26:957-962.
4. Bernátová, I, Pechánová O, Pelouch V, Šimko F. Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: effect of captopril. J Mol Cell Cardiol 2000; 32:177-185.
5. Moreno H Jr, Nathan LP, Costa SKP, Metze K, Antunes E, Zatz R, de Nucci G. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol 1995; 287:93-96.
6. G-nitro-L-arginine methyl ester-induced hypertension. Novel molecular adaptation to systolic load in absence of hypertrophy. Circulation 2000; 101:423-429.
7. Vozzo R, Wittert GA, Chapman IM, Fraser R, Hope PJ, Horowitz M, et al. Evidence that nitric oxide stimulates feeding in the marsupial Smithopsis crassicaudata. Comp Biochem Phys C 1999; 123:145-151.
8. Rossi MA, Colombini-Netto M. Chronic inhibition of NO synthesis per se promotes intimal structural remodelling of rat aorta. J Hypertens 2001; 19:1567-1579.
9. Rossi MA, Peres LC. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy. Am Heart J 1992; 124:700-709.
10. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998; 16:1031-1041.
11. Isoyama S, Sato F, Takishima T. Effect of age on coronary circulation after imposition of pressure-overload in rats. Hypertension 1991; 17:369-377.
12. Reichmann H, Hoppeler H, Mathieu-Costello O, von Bergen F, Pette D. Biochemical and ultrastructural changes of skeletal muscle mitochondria after chronic stimulation in rabbits. Pflugers Arch 1985; 404:1-9.
13. Onodera T, Tamura T, Said S, McClure SA, Martin Gerdes A, Maladaptive remodelling of cardiac myocyte shape begin long before failure in hypertension. Hypertension 1998; 32:753-757.
14. National Research Council. Subcommittee on Laboratory Animal Nutrition. Nutrient requirements of the laboratory rat. In: National Academy of Sciences, USA (editor): Nutrient requirements of laboratory animals. Washington, DC: National Academic Press; 1995, pp. 11-79.
15. Janati-Idrissi R, Basson B, Laplace M, Bui MH. In situ mitochondrial function in volume overload- and pressure overload-induced cardiac hypertrophy in rats. Basic Res Cardiol 1995; 90:303-313.
16. Kojda G, Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res 1999; 41:514-523.
17. Xie Y-W, Shen W, Zhao G, Xu X, Wolin MS, Hintze TH. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res 1996; 79:381-387.
18. Decking UKM, Williams JP, Dahmann R, Stumpe T, Kelm M, Schrader J. The nitric oxide-induced reduction in cardiac energy supply is not due to inhibition of creatine kinase. Cardiovasc Res 2001; 51:313-321.
19. Dai L, Brookes PS, Darley-Usmar VM, Anderson PG. Bioenergetics in cardiac hypertrophy: mitochondrial respiration as a pathological target of NO. Am J Physiol Circ Physiol 2001; 281:H2261-H2269.
20. Breisch EA, White FC, Bloor CM. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study. Lab Invest 1984; 51:333-342.
21. Lushnikova EL, Nepomniashchikh LM. Ultrastructural stereological analysis of the absolute parameters in myocardial hypertrophy. Biull Eksp Biol Med 1985; 99:619-622.
22. Olivetti G, Ricci R, Lagrasta C, Maniga E, Sonnenblick EH, Anversa P. Cellular basis of wall remodelling in long-term pressure overload-induced right ventricular hypertrophy in rats. Circ Res 1988; 63:648-657.
23. Zhang X, Xie Y-W, Nasjletti A, Xu X, Wolin MS, Hintze TH. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997; 95:176-182.
24. Takase H, Moreau P, Küng CF, Nava E, Lüscher TF. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996; 27:25-31.
25. Bernátová I, Pechánová O, Šimko F. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 1999; 84:1095-1105.
26. Akuzawa N, Nakamura T, Kurashina T, Saito Y, Hoshini J, Sakamoto H, et al. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis. Am J Hypertens 1998; 11:697-707.
27. Loke KE, McConnell PI, Tuzman JM, Shezely EG, Smith CJ, Stackpole CJ, et al. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 1999; 84:840-845.
28. Hropot M, Grotsch H, Klaus E, Langer KH, Linz W, Wiemer G, Scholkens BA. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Naunyn Schmiedeberg's Arch Pharmacol 1994; 350:646-652.
29. Linz W, Wiemer G, Schaper J, Unger T, Schölkens BA. Angiotensin-converting enzyme inhibitors, left ventricular hypertrophy and fibrosis. Mol Cell Biochem 1995; 147:89-97.
30. Kolpakov V, Gordon D, Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995; 75:305-309.
31. Hou J, Kato H, Cohen RA, Chobanian AV, Brecher P. Angiotensin II-induced cardiac fibrosis in the rat in increased by chronic inhibition of nitric oxide synthase. J Clin Invest 1995; 96:2469-2477.
32. 3 mRNA in rat cardiac fibroblasts via destabilization. Hypertension 2001; 38:261-266.